• Impact of vascular biology in treatment of cardiovascular disease
Section I: RAAS manipulation
The VBWG Core Curriculum 2003 slide lecture compendium, Impact of vascular biology in treatment of cardiovascular disease
, provides updates on new science and mechanisms of disease, plus implications of recent clinical trials.
Areas of focus:
The slides and accompanying notes in this section address modulation of the reninangiotensin- aldosterone system (RAAS) and new data that solidify its role in secondary prevention. In particular, there is particular focus on the "peri-interventional" period-the time immediately prior to and following hospital discharge-and on the evidence supporting rigorous adherence to multifactorial risk reduction regimens.
A. Epidemiology Update
Download 03RASS001.ppt (4 slides - 0.9MB)
B. Cell wall triggers for CV disease
Download 03RASS002.ppt (12 slides - 2.2MB)
C. Clinical trial update:
Download 03RASS003.ppt (28 slides - 5.3MB)
D. Diabetes and the peri-interventional patient
Download 03RASS004.ppt (12 slides - 2.4MB)
Published by Medical Education Consultants, Inc. (MEDCON), on behalf of the University of Florida College of Medicine.
The editorial content of this program does not necessarily reflect the views or recommendations of the University of Florida
College of Medicine or AstraZeneca, Aventis Pharmaceuticals Inc, King Pharmaceuticals, Pfizer Inc, Wyeth Pharmaceuticals,
or the publisher. The reader is advised to consult the full prescribing information of each product prior to use.
This program was prepared and produced by Medical Education Consultants, Inc, Westport, Connecticut, on behalf of the
University of Florida College of Medicine through an unrestricted educational grant provided by AstraZeneca, Aventis
Pharmaceuticals Inc, King Pharmaceuticals, Pfizer Inc, and Wyeth Pharmaceuticals.
©2003 Medical Education Consultants, Inc. (MEDCON). All rights reserved.